Lunai Bioworks Inc.
RENB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $477 | $150 | $32 | $101 |
| - Cash | $0 | $0 | $2 | $9 |
| + Debt | $10 | $4 | $6 | $7 |
| Enterprise Value | $487 | $154 | $36 | $99 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$189 | -$80 | -$39 | -$113 |
| % Margin | – | – | – | – |
| Net Income | -$178 | -$81 | -$40 | -$113 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.08 | -8.4 | -7.1 | -21.6 |
| % Growth | 87.1% | -18.3% | 67.1% | – |
| Operating Cash Flow | -$8 | -$11 | -$12 | -$16 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$8 | -$11 | -$12 | -$16 |